Invesaro

Stocks Comparison

Arcosa vs Proto Labs: revenue, profit, margins and growth compared

Arcosa brought in $2.9B of revenue in fiscal 2025, Proto Labs $533.1M in fiscal 2025. Revenue changed by +12.2% at Arcosa and +6.4% at Proto Labs on the year before, so Arcosa grew faster. Arcosa kept 7.2% of its revenue as net profit, Proto Labs 4.0%. Free cash flow was $175.5M at Arcosa and $59.7M at Proto Labs.

Open the ACA pageOpen the PRLB page

Side by side, latest fiscal year

ACAPRLB
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$2.9B$533.1M
Revenue growth+12.2%+6.4%
Net income$208.4M$21.2M
Net margin7.2%4.0%
Free cash flow$175.5M$59.7M
Free cash flow margin6.1%11.2%
Earnings per share (diluted)$4.24$0.88
Cash$214.6M$110.8M
Debt$1.5Bn/a
Price to earnings34.6109.4
Market value$7.2B$2.3B
Dividend yield0.14%n/a
Rank by revenue in sector#184 of 451 · Industrials#314 of 451 · Industrials

Over the years

Revenue
ACA FY2018: $1.5BACA FY2019: $1.7BACA FY2020: $1.9BACA FY2021: $2BACA FY2022: $2.2BACA FY2023: $2.3BACA FY2024: $2.6BACA FY2025: $2.9BPRLB FY2018: $445.6MPRLB FY2019: $458.7MPRLB FY2020: $434.4MPRLB FY2021: $488.1MPRLB FY2022: $488.4MPRLB FY2023: $503.9MPRLB FY2024: $500.9MPRLB FY2025: $533.1MFY18FY19FY20FY21FY22FY23FY24FY25
ACA $2.9BPRLB $533.1M
Net income
ACA FY2018: $75.7MACA FY2019: $113.3MACA FY2020: $106.6MACA FY2021: $69.6MACA FY2022: $245.8MACA FY2023: $159.2MACA FY2024: $93.7MACA FY2025: $208.4MPRLB FY2018: $76.6MPRLB FY2019: $63.7MPRLB FY2020: $50.9MPRLB FY2021: $33.4MPRLB FY2022: -$103.5MPRLB FY2023: $17.2MPRLB FY2024: $16.6MPRLB FY2025: $21.2MFY18FY19FY20FY21FY22FY23FY24FY25
ACA $208.4MPRLB $21.2M
Net margin
ACA FY2018: 5.2%ACA FY2019: 6.5%ACA FY2020: 5.5%ACA FY2021: 3.4%ACA FY2022: 11.0%ACA FY2023: 6.9%ACA FY2024: 3.6%ACA FY2025: 7.2%PRLB FY2018: 17.2%PRLB FY2019: 13.9%PRLB FY2020: 11.7%PRLB FY2021: 6.8%PRLB FY2022: -21.2%PRLB FY2023: 3.4%PRLB FY2024: 3.3%PRLB FY2025: 4.0%FY18FY19FY20FY21FY22FY23FY24FY25
ACA 7.2%PRLB 4.0%
Revenue growth
ACA FY2019: +18.9%ACA FY2020: +11.4%ACA FY2021: +5.2%ACA FY2022: +10.1%ACA FY2023: +2.9%ACA FY2024: +11.4%ACA FY2025: +12.2%PRLB FY2019: +2.9%PRLB FY2020: -5.3%PRLB FY2021: +12.4%PRLB FY2022: +0.1%PRLB FY2023: +3.2%PRLB FY2024: -0.6%PRLB FY2025: +6.4%FY19FY20FY21FY22FY23FY24FY25
ACA +12.2%PRLB +6.4%
Free cash flow
ACA FY2018: $73.7MACA FY2019: $273.4MACA FY2020: $177.8MACA FY2021: $81.4MACA FY2022: $36.3MACA FY2023: $57.5MACA FY2024: $312.3MACA FY2025: $175.5MPRLB FY2018: $35.8MPRLB FY2019: $53.8MPRLB FY2020: $60MPRLB FY2021: $21MPRLB FY2022: $40.4MPRLB FY2023: $45.2MPRLB FY2024: $68.7MPRLB FY2025: $59.7MFY18FY19FY20FY21FY22FY23FY24FY25
ACA $175.5MPRLB $59.7M

Fiscal years as each company reports them; the two may end in different months.

Questions about Arcosa and Proto Labs

Which is bigger by revenue, Arcosa or Proto Labs?

Arcosa is bigger by revenue: $2.9B in fiscal 2025, against $533.1M for Proto Labs in fiscal 2025.

Which keeps more of its revenue as profit, Arcosa or Proto Labs?

Arcosa had a net margin of 7.2% in fiscal 2025; Proto Labs had 4.0% in fiscal 2025.

Which grew revenue faster, Arcosa or Proto Labs?

In their latest fiscal years revenue changed by +12.2% at Arcosa and +6.4% at Proto Labs.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

ACA vs VMI
ACA vs VATE
ACA vs TPCS
PRLB vs VMI
PRLB vs VATE
PRLB vs TPCS

Compare more companies